Publication | Closed Access

Design, synthesis and antitumor evaluation of novel chiral diaryl substituted azetidin-2-one derivatives as tubulin polymerization inhibitors

Medicinal ChemistryAzetidin-2-one DerivativesMedicineDrug DiscoveryNovel Chiral DiarylTubulin Polymerization InhibitorsPharmacotherapyAnti-cancer AgentDrug DevelopmentPharmacologyPharmaceutical ChemistryBiomolecular Engineering